Nemes Rush Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.3K Buy
257
+20
+8% +$1.58K ﹤0.01% 479
2025
Q4
$19.4K Buy
237
+16
+7% +$1.25K ﹤0.01% 471
2025
Q3
$16.6K Sell
221
-609
-73% -$45.4K ﹤0.01% 440
2025
Q2
$61.5K Hold
830
0.01% 290
2025
Q1
$67K Sell
830
-19
-2% -$1.63K 0.01% 283
2024
Q4
$66.3K Buy
849
+611
+257% +$51.9K 0.01% 276
2024
Q3
$21.7K Sell
238
-262
-52% -$22K ﹤0.01% 337
2024
Q2
$39K Buy
500
+262
+110% +$21.4K 0.01% 283
2024
Q1
$21.7K Hold
238
﹤0.01% 368
2023
Q4
$18.4K Sell
238
-91
-28% -$6.37K ﹤0.01% 354
2023
Q3
$22.4K Sell
329
-35
-10% -$2.55K ﹤0.01% 329
2023
Q2
$29.6K Buy
+364
New +$29K 0.01% 319

Other funds holding GEHC

Nemes Rush Group's GEHC Position: Q1 2026 in Review

Nemes Rush Group increased its GE HealthCare (GEHC) stake by 8.4% in Q1 2026, buying an estimated $1.58K and bringing the position to 257 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

Nemes Rush Group first reported a position in GEHC in Q2 2023 and has held it in 12 quarters since. The position peaked at $67K in Q1 2025. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Nemes Rush Group held 257 shares of GE HealthCare worth $18.3K as of Q1 2026.
  • Nemes Rush Group bought 20 GE HealthCare shares in Q1 2026, an estimated $1.58K.
  • GE HealthCare made up ﹤0.01% of Nemes Rush Group's portfolio in Q1 2026, its #479 holding.
  • Nemes Rush Group first reported a position in GE HealthCare in Q2 2023 and has held it in 12 quarters since.
  • Nemes Rush Group's GE HealthCare position peaked at $67K in Q1 2025.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.